Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDC42SE1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | REPS1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | WBP4 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | CDCA7 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | GCC2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | COG8 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | ZNF391 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | CTD-2278I10.6 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | SFXN1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | ACPP | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |